The clinical effect of botulinum toxin on pigmentation

被引:2
|
作者
Erdil, Duygu [1 ]
Manav, Vildan [1 ]
Turk, Cemre B. [1 ]
Polat, Asude Kara [1 ]
Aksu, Ayse E. Koku [1 ]
机构
[1] Univ Hlth Sci Turkey, Istanbul Training & Res Hosp, Clin Dermatol, Istanbul, Turkey
关键词
SKIN; MELANOCYTES; ERYTHEMA; BIOLOGY; MELANIN;
D O I
10.1111/ijd.16522
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundBotulinum toxin injection is a common cosmetic procedure often used to treat dynamic wrinkles, but it has also been observed to have a lightening effect on the skin. It is thought that this lightening effect develops due to muscle innervation blockage; however, the change in the amount of melanin levels has not been quantified. MethodThirty-one patients who presented to the dermatology clinic of a tertiary hospital for botulinum toxin injection for wrinkle treatment were included in the study. A standard dose of botulinum toxin was injected to each patient's forehead, glabellar, and crow's feet region, and then the melanin index (MI) was measured with the Mexameter (R) MX 18 (Courage + Khazaka Electronic, Koln). ResultsAfter botulinum toxin treatment, a statistically significant decrease was found in the forehead and upper face MI. The upper face total baseline MI was significantly lower in the Glogau 1 group than in the Glogau 2 group (P = 0.033). The forehead 15th day MI was significantly lower in the Glogau 1 group than in the Glogau 2, 3, and 4 groups (P = 0.030). DiscussionBotulinum toxin application to healthy skin for wrinkle treatment can cause facial skin lightening by reducing MI. It was also remarkable that this decrease was more pronounced in the forehead, which is a region that is particularly vulnerable to sun exposure, compared to other regions. Younger people, who are included in the Glogau type 1 group, may benefit more from this lightening effect.
引用
收藏
页码:250 / 256
页数:7
相关论文
共 50 条
  • [21] BOTULINUM TOXIN IN CLINICAL-PRACTICE
    HUGHES, AJ
    DRUGS, 1994, 48 (06) : 888 - 893
  • [22] Clinical use of botulinum toxin A in the dog
    Switzer, E
    Meyer-Lindenberg, A
    Wohlfarth, K
    Nolte, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R47 - R47
  • [23] Current Clinical Applications of Botulinum Toxin
    Truong, Daniel D.
    Stenner, Andrea
    Reichel, Gerhard
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (31) : 3671 - 3680
  • [24] Clinical relevance of botulinum toxin immunogenicity
    Benecke R.
    BioDrugs, 2012, 26 (2) : e1 - e9
  • [25] Clinical relevance of botulinum toxin antibodies
    Dressler, D.
    NERVENARZT, 2008, 79 : 36 - 40
  • [26] Clinical effect of botulinum toxin on chronic masticatory muscle pain.
    Jang, S. K.
    Kim, C. Y.
    Cho, S. H.
    Park, T. S.
    Ko, M. Y.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B368 - B368
  • [27] Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F
    Roberto Eleopra
    Valeria Tugnoli
    Rocco Quatrale
    Ornella Rossetto
    Cesare Montecucco
    Dirk Dressler
    Neurotoxicity Research, 2006, 9 : 127 - 131
  • [28] Clinical use of non-A botulinum toxins: Botulinum toxin type C and botulinum toxin type F
    Eleopra, Roberto
    Tugnoli, Valeria
    Quatrale, Rocco
    Rossetto, Ornella
    Montecucco, Cesare
    Dressler, Dirk
    NEUROTOXICITY RESEARCH, 2006, 9 (2-3) : 127 - 131
  • [29] The Effect of Botulinum Toxin on the Platysma Muscle
    Bhertha M. Tamura
    Current Dermatology Reports, 2012, 1 (2): : 89 - 95
  • [30] EFFECT OF TREATMENT WITH BOTULINUM TOXIN ON SPASTICITY
    DAS, TK
    PARK, DM
    POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (762) : 208 - 210